ESMO COLLOQUIUM Sessions

ESMO Colloquium: Recurrent glioblastoma management: Challenges and opportunities

30 Sep 2019

This educational activity is provided by ESMO and supported by Apogenix.
View the ESMO colloquium details

ESMO Colloquium: Pancreatic cancer: Can better understanding of biology improve resectability and survival?

30 Sep 2019

This educational activity is provided by ESMO and supported by Celgene.
View the ESMO colloquium details

ESMO Colloquium: Metastatic gastro-intestinal cancer: Multiple treatment lines, extended pipeline of available drugs and use of predictive markers.
How to best sequence the treatment proposal?

29 Sep 2019

This educational activity is provided by ESMO and supported by Lilly Oncology.
View the ESMO colloquium details

ESMO Colloquium: Relapsed/Refractory FLT3-ITD positive Acute Myeloid Leukemias (AML)

29 Sep 2019

This educational activity is provided by ESMO and supported by Daiichi Sankyo Europe GmbH.
View the ESMO colloquium details

ESMO Colloquium: Metastatic clear cell renal cell carcinoma: How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting?

29 Sep 2019

This educational activity is provided by ESMO and supported by Ipsen.
View the ESMO colloquium details

ESMO Colloquium: Emerging biotherapy strategies in the treatment of solid tumours: Hope, Hype and Hurdles

28 Sep 2019

This educational activity is provided by ESMO and supported by Eisai Europe.
View the ESMO colloquium details

*Resources are not available.

All ESMO 2019 Resources

Last update: 23 October 2018